Jump to section
To ensure that every deadly breast cancer is detected early.
Early detection is a critical factor in the battle against breast cancer, a disease that afflicts over 2 million women worldwide each year and ranks as the most prevalent cancer among women. Vara, an innovative player in the healthcare sector, is committed to enhancing survival rates by harnessing the power of AI.
What sets Vara apart is its strategic focus on simplifying detection processes, particularly through workload reduction. This approach has garnered widespread enthusiasm among radiologists, who appreciate the seamless integration of Vara's technology into their existing workflows.
Originating in Germany, Vara has been expanding its footprint across Europe. It is also exploring new avenues for its extensive data stores, and recently received regulatory approval for its tomosynthesis (3D mammography) AI solution. This puts Vara in a great position to make a meaningful impact on breast cancer detection, potentially improving outcomes for countless women around the world.

Freddie
Company Specialist at Welcome to the Jungle
Jonas Muff
(CEO & Co-Founder)Previously Jonas worked at a venture studio called Merantix from which he successfully spun out another German HealthTech startup called MX Healthcare.
Stefan Bunk
(CTO & Co-Founder)Created venture studio Merantix's first core machine learning infrastructure before founding Vara.